Biosimilars, Generic Drugs, and the Pharmaceutical Industry

biosimilars

Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading

The New Study of The Old Proteins: Palaeoproteomics

Palaeoproteomics

A new field, palaeoproteomics—the study of ancient proteins—has been receiving more attention, leading to proposed guidelines that will establish a foundation for research. Proteins have the ability to preserve ten Continue Reading

Is Your LC Column for Biologics Analysis, Truly Bio-Inert?

Let’s talk about column priming and how to address this common concern Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager With the emerging trend of biotherapeutics in the pharmaceutical industry, Continue Reading

Large vs Small Organic Molecules in Biopharmaceuticals

Biopharmaceuticals

Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager The pharmaceutical industry has a long-standing Continue Reading